Literature DB >> 11405232

Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.

K Jansen1, O Schäfer, E Birkmann, K Post, H Serban, S B Prusiner, D Riesner.   

Abstract

The conversion of the alpha-helical, protease sensitive and noninfectious form of the prion protein (PrP(C)) into an insoluble, protease resistant, predominantly beta-sheeted and infectious form (PrP(Sc)) is the fundamental event in prion formation. In the present work, two soluble and stable intermediate structural states are newly identified for recombinant Syrian hamster PrP(90-231) (recPrP), a dimeric alpha-helical state and a tetra- or oligomeric, beta-sheet rich state. In 0.2% SDS at room temperature, recPrP is soluble and exhibits alpha-helical and random coil secondary structure as determined by circular dichroism. Reduction of the SDS concentration to 0.06% leads first to a small increase in alpha-helical content, whereas further dilution to 0.02% results in the aquisition of beta-sheet structure. The reversible transition curve is sigmoidal within a narrow range of SDS concentrations (0.04 to 0.02%). Size exclusion chromatography and chemical crosslinking revealed that the alpha-helical form is dimeric, while the beta-sheet rich form is tetra- or oligomeric. Both the alpha-helical and beta-sheet rich intermediates are soluble and stable. Thus, they should be accessible to further structural and mechanistic studies. At 0.01% SDS, the oligomeric intermediates aggregated into large, insoluble structures as observed by fluorescence correlation spectroscopy. Our results are discussed with respect to the mechanism of PrP(Sc) formation and the propagation of prions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11405232     DOI: 10.1515/BC.2001.081

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  21 in total

1.  Mechanisms of prion protein assembly into amyloid.

Authors:  Jan Stöhr; Nicole Weinmann; Holger Wille; Tina Kaimann; Luitgard Nagel-Steger; Eva Birkmann; Giannantonio Panza; Stanley B Prusiner; Manfred Eigen; Detlev Riesner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

2.  Single-molecule approaches to prion protein misfolding.

Authors:  Hao Yu; Derek R Dee; Michael T Woodside
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

3.  Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice.

Authors:  Jan Stöhr; Carlo Condello; Joel C Watts; Lillian Bloch; Abby Oehler; Mimi Nick; Stephen J DeArmond; Kurt Giles; William F DeGrado; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

4.  Isolation and characterization of a polymerized prion protein.

Authors:  Bao-Yuan Lu; Jui-Yoa Chang
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

5.  Structural changes of membrane-anchored native PrP(C).

Authors:  Kerstin Elfrink; Julian Ollesch; Jan Stöhr; Dieter Willbold; Detlev Riesner; Klaus Gerwert
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

6.  Homodimerization as a molecular switch between low and high efficiency PrP C cell surface delivery and neuroprotective activity.

Authors:  Maxime Béland; Xavier Roucou
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

Review 7.  Prion infection: seeded fibrillization or more?

Authors:  Eva Birkmann; Detlev Riesner
Journal:  Prion       Date:  2008-04-23       Impact factor: 3.931

8.  2-Aminothiazoles with improved pharmacotherapeutic properties for treatment of prion disease.

Authors:  Zhe Li; B Michael Silber; Satish Rao; Joel R Gever; Clifford Bryant; Alejandra Gallardo-Godoy; Elena Dolghih; Kartika Widjaja; Manuel Elepano; Matthew P Jacobson; Stanley B Prusiner; Adam R Renslo
Journal:  ChemMedChem       Date:  2013-03-18       Impact factor: 3.466

9.  Subclinical prion disease induced by oral inoculation.

Authors:  Alana M Thackray; Michael A Klein; Raymond Bujdoso
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Toxic effects of intracerebral PrP antibody administration during the course of BSE infection in mice.

Authors:  Maxime Lefebvre-Roque; Elisabeth Kremmer; Sabine Gilch; Wen-Quan Zou; Cécile Féraudet; Chantal Mourton Gilles; Nicole Salès; Jacques Grassi; Pierluigi Gambetti; Thierry Baron; Hermann Schätzl; Corinne Ida Lasmézas
Journal:  Prion       Date:  2007-07-15       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.